Circular RNAs (circRNA) are hotspot members of non -coding RNA networks, which have a variety of characteristics and pathophysiological functions. CircRNA plays roles in epigenetic, transcriptional, and post -transcriptional regulation. At present, the number of validated endogenous circRNA involved in ovarian cancer continues increasing and many circRNA expressions are related to the occurrence, invasion and metastasis of ovarian cancer. In addition, the abnormal expression of circRNA is also closely related to the stage, volume of tumor, differentiation and metastasis of ovarian cancer. Because of their high stability, highly conserved, and tissue-specific expression patterns, circRNA may become potential markers of ovarian cancer for the diagnosis. This article reviews the current research reports of circRNA related to ovarian cancer, proposes its impact on the occurrence of ovarian cancer and its potential value as a diagnostic and prognostic biomarker and as a therapeutic target for ovarian cancer, and explores circRNA′ s impacts of chemotherapy resistance for ovarian cancer. Finally, the clinical potential and future research directions of circRNA related to ovarian cancer are discussed. Circular RNAs (circRNA) are hotspot members of non -coding RNA networks, which have a variety of characteristics and pathophysiological functions. CircRNA plays roles in epigenetic, transcriptional, and post -transcriptional regulation. At present, the number of validated endogenous circRNA involved in ovarian cancer continues increasing and many circRNA expressions are related to the occurrence, invasion and metastasis of ovarian cancer. In addition, the abnormal expression of circRNA is also closely related to the stage, volume of tumor, differentiation and metastasis of ovarian cancer. Because of their high stability, highly conserved, and tissue-specific expression patterns, circRNA may become potential markers of ovarian cancer for the diagnosis. This article reviews the current research reports of circRNA related to ovarian cancer, proposes its impact on the occurrence of ovarian cancer and its potential value as a diagnostic and prognostic biomarker and as a therapeutic target for ovarian cancer, and explores circRNA′ s impacts of chemotherapy resistance for ovarian cancer. Finally, the clinical potential and future research directions of circRNA related to ovarian cancer are discussed. [ABSTRACT FROM AUTHOR]